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Objective: Microwave ablation has been reported as efficient for the surgical treatment of long-standing atrial
fibrillation. However, the influence of ablation lesions on long-term results is not known.
Methods: From August of 2000 to November of 2003, 41 patients underwent a left atrial endocardial microwave
ablation procedure after a Cox-Maze–like lesion set for long-standing atrial fibrillation concomitant to surgery for
valvular or coronary artery disease. Mitral valve surgery alone or combined was performed in 31 cases (75.6%).
The mean diameter of the left atrium was 7.19 1.44 cm. The mean duration of preoperative atrial fibrillation was
4.7  3.6 years. Patient follow-up was conducted by means of direct clinical examination, electrocardiography,
and transthoracic echocardiography. The mean follow-up was 5.37  0.91 years.
Results: Patient follow-up was achieved in 82% of cases (n¼ 28). Seven patients (17%) died during follow-up.
Stroke was the cause of death in 1 patient with persistence of atrial fibrillation. Major complications occurred in 4
(14.3%) of the patients that were related to the persistence of atrial fibrillation. At 5 years follow-up, 39.3% of
patients (11/28) were in sinus rhythm. Seventeen patients (60.7%) were in New York Heart Association classes I
and II, and 11 patients (39.3%) were in New York Heart Association class III at the time of follow-up.
Conclusion: In our experience, left atrial endocardial microwave ablation for long-standing atrial fibrillation after
a Cox-Maze–like ablation lesion set during surgery for organic heart disease is not a reliable method of achieving
long-term conversion to sinus rhythm.With the renewed interest in the surgical treatment of atrial
fibrillation (AF) energized by the introduction of alternative
energy sources, microwave energy has been deemed to be
safe and effective. However, little is known about micro-
wave ablation as it relates to its long-term efficacy when
used to perform the Cox-Maze procedure. As part of an
ongoing study, our prospective database was reviewed to
evaluate the long-term freedom from late AF recurrence in
41 patients who underwent a left-sided Cox-Maze lesion
set using a microwave device as the alternate energy source
at the Großhadern Medical Center.
MATERIALS AND METHODS
Between August of 2000 and November of 2003, 41 patients at the
Großhadern Medical Center underwent an endocardial left atrial microwave
ablation procedure for persistent AF concomitant to open surgery for or-
ganic cardiac disease. The study was approved by the ethics committee of
the Großhadern Medical Center, and informed consent was obtained from
each patient. There were 21 female and 20 male patients with a mean age
of 66.4  10.3 years (range 37–81 years). All patients had long-standing
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ysmal AF was included in the study. The following concomitant procedures
were performed: mitral valve surgery (n¼ 26; 63.4%), aortic valve surgery
(n¼ 6; 14.6%), coronary artery surgery (n¼ 2; 5%), tricuspid valve repair
(n ¼ 1; 2.4%), mitral and aortic valve surgery (n ¼ 4; 9.8%), mitral valve
and coronary artery surgery (n ¼ 1; 2.4%), and aortic valve and coronary
artery surgery (n ¼ 1; 2.4%).
A microwave system (AFx Inc, Fremont, Calif) was used for the abla-
tion. The generator delivers a continuous energy flow (2.45 GHz), which
allowed for variable power output ranging between 35 and 75W, adjustable
by 5W increments. The Flex 2 probe was used in this study, and it consisted
of a 25-mm–long ablation antenna. The temperature of the device was
recorded through an embedded thermocouple, and the ablation element
was cooled down after 5 to 6 ablations to keep the temperature less than
40C to prevent overheating and uncontrolled tissue damage.
The microwave energy power setting used to produce each lesion was
40W,with an ablation time of 25 seconds. The number of applications ranged
from 17 to 38. The ablation lesion set consisted of a continuous ablation line
encircling all 4 pulmonary vein orifices: starting at the level of the mid-mural
mitral annulus and going to the left inferior pulmonary vein, then to the left
superior pulmonary vein, continuing across the posterior wall of the left
atrium to the right superior pulmonary vein, then to the right inferior pulmo-
nary vein, and finally to themitral valve annulus, and terminating attending at
the place the procedure began. The left atrial appendage was excluded by
oversewing, and the base of the appendage was surrounded by another
continuous ablation line starting from the left superior pulmonary vein.1
All patients underwent arrested heart surgery under cardiopulmonary
bypass using a standard procedure via a median sternotomy. The ablation
lesion set was performed before valve or coronary artery surgery.
The preoperative and postoperative protocols have been presented in
a previous publication.1
Patient follow-up was conducted by means of clinical examination,
a recent electrocardiogram (ECG), and transthoracic echocardiographic
studies.urgery c November 2008




AF ¼ atrial fibrillation
ECG ¼ electrocardiogram
NYHA ¼ New York Heart Association
Statistical Analysis
In 2004, the Department of Cardiac Surgery at the Großhadern Medical
Center changed from the use of microwave to radiofrequency energy-based
devices for ablation of AF after some reports suggested a better outcome us-
ing radiofrequency. We performed a short-term follow-up after ablation of
AF using radiofrequency devices that demonstrated a conversion rate of
up to 80%. We had obtained the same results using microwave energy;
thus, the question was asked whether the 2 types of energy would have the
same results in a long-term follow-up. In answer to this question, we initiated
a retrospective study on the patient population who underwent a microwave
ablation in the Department of Cardiac Surgery, which is why we can present
only the last follow-up data and could not create a Kaplan–Meier curve.
For computer-assisted statistical data analysis, the Statistical Package for
the Social Sciences was used (14.0 for Windows; SPSS Inc, Chicago, Ill).
Values of continuous variables are expressed as mean standard deviation.
The Student t test was used for parametric variables and the chi-square test
was used for categoric variables to calculate probability values. For follow-
up variables, the Wilcoxon rank-sum test was calculated.
RESULTS
One-year follow-up results for the first 24 patients have
been presented.1 Long-term follow-up was performed at
5.37  0.91 years (range 3.44–6.74 years). There were 7
deaths during the follow-up period. Stroke was the cause
of death in 1 patient. In the remainder of patients, the cause
of death was unknown. Of the 34 survivors, 28 patients
(82%) were investigated. In all patients, anamnesis, clinical
investigation, 12-lead ECG, and transthoracic echocardiog-
raphy were performed. One patient with persistent AF had
a stroke resulting in hemiplegia. One patient had a transient
ischemic attack, and 1 patient had a peripheral embolic event
that was successfully treated by embolectomy. Percutaneous
catheter ablation was unsuccessfully performed in 1 patient.
Long-term restoration of sinus rhythm was documented in
39.3% of patients (11/28). All patients in sinus rhythm
were not taking any antiarrhythmic medication. Seventeen
patients (60.7%) were in New York Heart Association
(NYHA) classes I and II, and 11 patients (39.3%) were in
NYHA class III at the time of follow-up. There were no sig-
nificant differences between the NYHA class of patients in
sinus rhythm and those patients with persistent AF. The
mean duration of preoperative AF was 4.7  3.6 years
(range 1–15 years). The mean diameter of the left atrium
was 7.19  1.44 cm (range 4.6–10.5 cm). The left atrial di-
ameter was significantly reduced in all patients, with a mean
of 5 0.76 cm in patients with sinus rhythm and 5.1 0.67
cm in patients with persistence of AF compared with the pre-
operative data: P ¼ .02 for the patients in sinus rhythm and
P ¼ .003 for the patients with persistence of AF. We wereThe Journal of Thoracic and Cunable to demonstrate any statistical significance with re-
gard to risk factors for persistence of AF. Preoperative dura-
tion of AF was longer in patients with persistent AF at late
follow-up (5.6 4.1 years) compared with the patients in si-
nus rhythm (3.71  2.6 years), but this was not statistically
significant. The type of surgery did not influence the results.
At late follow-up, 7 patients were in sinus rhythm after mi-
tral valve surgery and 4 patients were in sinus rhythm after
other procedures (P ¼ .7).
DISCUSSION
The aim of surgical treatment of AF is to restore sinus
rhythm. The success rate is different among published
data, varying from 42% to 100%.2,3 Among the reasons
for the difference in results are the following: different crite-
ria for patient selection, incidence of preoperative paroxys-
mal AF, incidence of preoperative lone AF, application
site of ablation energy (endocardial or epicardial), method
to produce the lesions (cut-and-sew or alternative sources
of energy), lesion set, and definition of success.
Most surgical ablation procedures are performed concom-
itantly to cardiac surgery for valvular or coronary artery
disease, and most of the patients have persistent, long-
standing AF.
The cut-and-sew Cox-Maze procedure is considered the
gold standard for surgical treatment of AF. However, the
perceived technical complexity and longer procedure times
have prevented its widespread adoption into clinical routine.
Alternative energy sources, including radiofrequency,
microwave, cryoablation, high-intensity focus ultrasound,
and laser energy, have been developed to simplify the surgi-
cal treatment of AF. The endocardial surface is the most
frequent energy application site, and in most cases only
the left atrial lesion pattern is performed.4
There has been some controversy in the literature as to
whether the creation of transmural lesions is necessary to
cure AF. However, it is an accepted fact that lesions must
create a conduction block to be effective as a treatment for
AF.5 Ablation lines are designed to electrically isolate the
triggers in the pulmonary veins or block the macro-reentrant
circuits responsible for the propagation of permanent AF.
However, the only guarantee of complete and permanent
conduction block is a transmural lesion.6
In consideration of the above-presented commentaries,
the most frequent ‘‘ablation-scenario’’ occurs during sur-
gery for organic heart diseases and the lesions are performed
on the endocardial surface of the left atrium. Further, if the
energy source used produces transmural lesions, then results
should be influenced only by lesion set and patient character-
istics.
The left atrial Cox-Maze lesion set was developed to inter-
rupt the multiple wavelet macro-reentry circuits that perpet-
uate AF and has the best long-term results with a conversion
rate to sinus rhythm of approximately 95% at 15 years.7ardiovascular Surgery c Volume 136, Number 5 1157
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duration of AF and the diameter of the left atrium are impor-
tant variables that significantly influence the success of the
procedure.8,9 Frequently mentioned cutoff values are preop-
erative left atrial diameter less than 6 cm and duration of AF
less than 6 years.10-12 One can therefore conclude that if pre-
operative duration of persistent, long-standing AF is not ex-
cessive and the enlargement of the left atrium is not extreme,
left atrial endocardial ablation using a Cox-Maze–like lesion
set with a device capable of producing transmural lesions
should have good results. In our experience using micro-
wave energy, the initial conversion rate to sinus rhythm
was 80% after 1 year in 24 patients,1 but this decreased dra-
matically to 39.3% after 5.37 years in a larger patient pop-
ulation resulting from the addition of 17 supplementary
patients. The diameter of the left atrium was 7.19 cm and
the duration of preoperative AF was 4.7 years in our entire
patient population. At follow-up, we noticed a significant re-
duction in the left atrial diameter compared with the preop-
erative status (P¼ .02) in patients converted to sinus rhythm
(left atrial diameter at last follow-up: 5 cm) and in patients
who remained in AF (5.1 cm). There was no difference re-
garding this parameter between the 2 groups. On the basis
of these results, we assume that surgery for the organic heart
diseases led to a significant reduction of the left atrial diam-
eter in both groups. On consideration of these data, we con-
clude that the dimension of the left atrium did not influence
the poor conversion rate of our followed patients. The preop-
erative duration of AF of 4.7 years in our patient population
is a rather short time period compared with other studies, so
it cannot be considered as a determinant for the poor conver-
sion rate to sinus rhythm.10-12
The current system of microwave ablation lacks a trans-
murality feedback mechanism. This is in contrast with the
bipolar radiofrequency system, which has an adjustable en-
ergy delivery mechanism dependent on tissue thickness and
is a reliable indicator for lesion transmurality.13 The micro-
wave energy delivery is based on a standard protocol recom-
mended by the company that produces the device, which is
based on the results of in vitro or animal experiments. For the
Flex 2 device, if microwave energy is applied endocardially,
most of the authors use an energy power of 40W with an
ablation time of 25 seconds per lesion at a frequency of
2.45 GHz.1,14,15 Venturini and colleagues16 have suggested
higher microwave energy levels (65W) and a longer ablation
time per lesion (60 seconds). This setting has also been
recommended by the device manufacturers for epicardial
application of microwave energy for beating heart ablation
of AF.17
The ability of the microwave system to create transmural
lesions consistently in the arrested heart of a porcine model
was described by Gaynor and colleagues.6 They created en-
docardial atrial lesions at 65W and different durations of 15,
30, 45, 60, 90, and 120 seconds. All lesions were transmural1158 The Journal of Thoracic and Cardiovascular Swith ablation duration of 90 seconds. The lesions that were
not transmural were over the trabeculated areas of the atria.
On the basis of their results, Gaynor and colleagues con-
cluded that more prolonged ablation will be required in pa-
tients if atrial wall thickness exceeds 4 mm.
In our patient population, the lesion set was similar to the
left Cox-Maze cut-and-sew procedure, and the microwave
energy power setting used to produce each lesion was
40W, with an ablation time of 25 seconds. It is possible
that transmurality was not accomplished in all ablated areas.
This could be an explanation for the modest conversion rate
to sinus rhythm at 5.4 years. The conversion rate in this pa-
tient population was 80% at 1-year follow-up.1 To our
knowledge, the longest follow-up data after microwave ab-
lation available in the literature is 1 year. The reported con-
version rates ranged from 62% to 88%.15,18
There is a paucity of publications reporting long-term ab-
lation results. If the cut-and-sew Cox-Maze procedure is
used, the reported results are better. Gaynor and colleagues8
reported a success rate of 89.3% at 10 years after the cut-
and-sew Cox-Maze procedure. However, 66% of the pa-
tients underwent surgery for lone AF. Similar results were
reported by Itoh and colleagues:19 98.4% at 5 years and
81% at 12 years. The conversion rate reported by Sie and
colleagues20 was 73.4% at a follow-up duration of 3.3 years
using unipolar radiofrequency energy. The logical question
is, should 1-year results be considered definitive regarding
conversion rate success, or should follow-up be prolonged
to demonstrate persistence of sinus rhythm, especially if
transmurality of lesions created during surgery is not
certain?
Theoretically, conversion to sinus rhythm should lead to
significantly higher reduction in left atrial diameter com-
pared with the reduction of this parameter in patients with
persistence of AF after surgical correction of organic heart
diseases. However, to our knowledge only 1 study has dem-
onstrated a statistically significant result with regard to this
difference.14 There are 2 other publications that have docu-
mented a significant reduction in left atrial diameter after
heart surgery but failed to find any difference between
patients with sinus rhythm and patients with AF at follow-
up.21,22 The patients in these studies underwent surgery
because of mitral valve disease. The authors stated that the
mitral valve procedures caused a considerable reduction in
left atrial size, the magnitude of which was similar in all pro-
cedures. This was probably caused by mitral valve correc-
tion resulting in left atrial pressure relief. We observed
a similar finding in our patient population. The diameter of
the left atrium at 5 years follow-up in patients with sinus
rhythm did not differ compared with the left atrial diameter
in patients with AF with the same follow-up duration. How-
ever, preoperative left atrial diameter was larger in patients
with AF versus patients who were in sinus rhythm. Overall,
there was a reduction of the left atrial diameter in all patientsurgery c November 2008
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a consequence of the surgical correction of the organic heart
disease. In our patient population, conversion to sinus
rhythm did not seem to influence the reduction in left atrial
size.
LIMITATIONS
This study has several limitations. The small patient pop-
ulation along with the number of patients lost to follow-up
may have affected the results. Documentation of pulmonary
vein isolation by pacing at the time of surgery may have
given an indication of the inability of the device to create
transmural lesions acutely. The fact that all patients had
long-standing AF and were treated with only a left-sided
lesion set also may have influenced the results. Reliance
on patient history and ECG to evaluate sinus rhythm may
have resulted in an underestimation of AF recurrence. A
more accurate method would have entailed the use of a
Holter monitor or cardiac event monitor.
CONCLUSIONS
We recognize several factors that influence the success of
the Cox-Maze procedure, as outlined above. However, on
the basis of our findings, one can assume that a lack of lesion
transmurality was a major factor influencing the modest con-
version rate to sinus rhythm 5 years postoperatively.
References
1. Schuetz A, Schulze CJ, Sarvanakis KK, Mair H, Plazer H, Kilger E, et al. Surgical
treatment of permanent atrial fibrillation using microwave energy ablation: a pro-
spective randomized clinical trial. Eur J Cardiothorac Surg. 2003;24:475-80.
2. Melo J, Adragao P, Neves J, Ferreira M, Timoteo A, Santiago T, et al. Endocardial
and epicardial radiofrequency ablation in the treatment of atrial fibrillation with
a new intraoperative device. Eur J Cardiothorac Surg. 2000;18:182-6.
3. Loennerholm S, Blomstroem P, Nilson L, Oxelbark S, Jideus L, Blomstroem LC.
Effects of the maze operation on the health-related quality of life in patients with
atrial fibrillation. Circulation. 2000;101:2607-11.
4. Khargi K, Hutten BA, Lemke B, Deneke T. Surgical treatment of atrial fibrilla-
tion; a systematic review. Eur J Cardiothorac Surg. 2005;27:258-65.
5. Cox JL, Canavan TE, Schuessler RB. The surgical treatment of atrial fibrillation:
intraoperative electrophysiological mapping and description of the electrophysi-
ological basis of atrial flutter and atrial fibrillation. J Thorac Cardiovasc Surg.
1991;101:406-26.The Journal of Thoracic and C6. Gaynor S, Byrd GD, Diodato MD, Ishii Y, Lee AM, Prasad SM, et al. Microwave
ablation for atrial fibrillation: dose-response curves in the cardioplegia-arrested
and beating heart. Ann Thorac Surg. 2006;81:72-7.
7. Cox JL. Cardiac surgery for arrhythmias. J Cardiovasc Electrophysiol. 2004;15:
250-62.
8. Gaynor SL, Schuessler RB, Bailey MS, Ishii Y, Boineau JP, Gleva MJ, et al. Sur-
gical treatment of atrial fibrillation: predictors of late recurrence. J Thorac Cardi-
ovasc Surg. 2005;129:104-11.
9. Gillinov AM, Sirak J, Blackstone EH, McCarthy PM, Rajeswaran J, Petersson G,
et al. The Coxmaze procedure in mitral valve disease: predictors of recurrent atrial
fibrillation. J Thorac Cardiovasc Surg. 2005;130:1653-60.
10. Chen MC, Chang JP, Chang HW, Chen CJ, Yang CH, Chen YH, et al. Clinical
determinants of sinus conversion by radiofrequency maze procedure for persistent
atrial fibrillation in patients undergoing concomitant mitral valvular surgery. Am J
Cardiol. 2005;96:1553-7.
11. Halkos ME, Craver JM, Thourani VH, Kerendi F, Puskas JD, Cooper WA, et al.
Intraoperative radiofrequency ablation for the treatment of atrial fibrillation during
concomitant cardiac surgery. Ann Thorac Surg. 2005;80:210-6.
12. Geidel S, Lass M, Boczor S, Kuck KH, Ostermeyer J. Monopolar and bipolar
radiofrequency ablation surgery: 3-year experience in 90 patients with permanent
atrial fibrillation. Heart Surg Forum. 2004;7:404-8.
13. Gaynor SL, Ishii Y, Diodato MD, Prasad SM, Barnett KM, Schuessler RB, et al.
The successful performance of the Cox-Maze procedure on the beating heart using
bipolar radiofrequency ablation: feasibility study in animals. Ann Thorac Surg.
2004;78:1671-7.
14. Zembala M, Lenarczyk R, Kalarus Z, Puszczewicz D, Przybylski R,
Pacholewicz J. Early and late outcome after microwave ablation for chronic
valvular atrial fibrillation. Heart Surg Forum. 2003;6:403-8.
15. Wisser W, Khazen C, Deviatko E, Stix G, Binder T, Seitelberger R, et al.
Microwave and radiofrequency ablation yield similar success rates for treat-
ment of chronic atrial fibrillation. Eur J Cardiothorac Surg. 2004;25:
1011-7.
16. Venturini A, Polesel E, Cutaia V, Asta A, Mangino D, Moretti R, et al. Intraoper-
ative microwave ablation in patients undergoing valvular surgery: midterm re-
sults. Heart Surg Forum. 2003;6:409-11.
17. Williams MR, Argenziano M, Oz MC. Microwave ablation for surgical treatment
of atrial fibrillation. Semin Thorac Cardiovasc Surg. 2002;14:232-7.
18. Knaut M, Tugtekin SM, Jung F, Matschke K. Microwave ablation for the surgical
treatment of permanent atrial fibrillation—a single centre experience. Eur J
Cardiothorac Surg. 2004;26:742-6.
19. Itoh A, Kobayashi J, Bando K, Niwaya K, Tagusari O, Nakajima H, et al. The im-
pact of mitral valve surgery combined with maze procedure. Eur J Cardiothorac
Surg. 2006;29:1030-5.
20. Sie HT, BeukemaWP, Elvan A,Misier ARR. Long-term results of irrigated radio-
frequency modified maze procedure in 200 patients with concomitant cardiac
surgery: six years experience. Ann Thorac Surg. 2004;77:512-7.
21. De Lima GG, Kalil RAK, Leiria TLL, Hatem DM, Kruse CL, Abrahao R, et al.
Randomized study of surgery for patients with permanent atrial fibrillation as a re-
sult of mitral valve disease. Ann Thorac Surg. 2004;77:2089-95.
22. Filho CACA, Lisboa LAF, Dallan LAO, Spina GS, Grinberg M, Scanavacca M,
et al. Effectiveness of the maze procedure using cooled-tip radiofrequency abla-
tion in patients with permanent atrial fibrillation and rheumatic mitral valve
disease. Circulation. 2005;112:I-20-5.ardiovascular Surgery c Volume 136, Number 5 1159
